Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Omaha, Nebraska 68198


The purpose of this study is to look at the progression of cardiovascular disease (CVD) in normal control individuals and in patients with controlled diabetes.

Study summary:

Cardiovascular disease remains the greatest cause of mortality in people with diabetes mellitus. This observation study will evaluate non-traditional risk factors for their contributions to vascular disease progression as determined by carotid intima media thickness and history of vascular disease events over 1 year. This study requires annual checks of blood, urine, history, and carotid ultrasound for carotid intimal medical thickness.


Inclusion Criteria: - 19 years old or more and willing to return for annual testing for 2 years. - Those with Diabetes need to have the condition for at least 5 years. - Normal controls need to have no diabetes, kidney disease, or chronic disease. Exclusion Criteria: - Estimated GFR <60 (mL/min/1.73m2) - Any condition that would change weight dramatically in the near future such as malabsorption, pregnancy, malignancy - For Normal: BMI>30, BP > 140/90 , LDL > 130. - For Diabetes: BP> 135/85, A1C> 8%. LDL > 100.

Study is Available At:

Original ID:




Secondary ID:

Study Acronym:

Brief Title:

Vascular Risk Progression in Normal and Diabetic Control Subjects.

Official Title:

Vascular Risk Progression in Normal and Diabetes Control Subjects

Overall Status:


Study Phase:




Minimum Age:

19 Years

Maximum Age:

80 Years

Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

University of Nebraska

Oversight Authority:

United States: Institutional Review Board

Reasons Why Stopped:

Study Type:


Study Design:

Number of Arms:


Number of Groups:


Total Enrollment:


Enrollment Type:


Overall Contact Information

Official Name:Jennifer Larsen, MD
Principal Investigator

Study Dates

Start Date:March 2007
Completion Date:March 29, 2018
Completion Type:Actual
Primary Completion Date:March 29, 2018
Primary Completion Type:Actual
Verification Date:March 2018
Last Changed Date:March 29, 2018
First Received Date:December 19, 2007

Study Outcomes

Outcome Type:Primary Outcome
Measure:To describe carotid intima media measurement change over 2 year period in normal individuals compared to individuals with well controlled diabetes
Time Frame:2 years
Safety Issues:False

Study Interventions

There are no available Study Interventions

Study Arms

Study Arm Type:Other
Arm Name:1
Description:Normal controls both men and women
Study Arm Type:Other
Arm Name:2
Description:Individuals with type 2 Diabetes with good control
Study Arm Type:Other
Arm Name:3
Description:Individuals with type 1 diabetes with good control

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:University of Nebraska

Samples and Retentions

Study Population: Any patient with diabetes or healthy individuals
Sample Method:Non-Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

This study is not currently recruiting Study Participants. The form below is not enabled.